Panel’s Split Decision On Dyax HAE Drug Belies Consensus On Clinical Data

Advisory panel concerned with limited efficacy and safety data; members express uncertainty over standards for orphan drug approval.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet